KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Shares Outstanding (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Shares Outstanding for 10 consecutive years, with $41.4 million as the latest value for Q3 2021.

  • On a quarterly basis, Shares Outstanding changed N/A to $41.4 million in Q3 2021 year-over-year; TTM through Sep 2021 was $41.4 million, a N/A change, with the full-year FY2020 number at $33.0 million, changed N/A from a year prior.
  • Shares Outstanding was $43.3 million for Q1 2023 at Biolife Solutions, up from $41.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $43.3 million in Q1 2023 to a low of $20.3 million in Q3 2019.
  • A 4-year average of $29.3 million and a median of $26.0 million in 2020 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: increased 9.0% in 2017, then surged 56.11% in 2021.
  • Biolife Solutions' Shares Outstanding stood at $14.0 million in 2017, then skyrocketed by 32.28% to $18.5 million in 2018, then skyrocketed by 40.09% to $26.0 million in 2020, then soared by 59.51% to $41.4 million in 2021.
  • Per Business Quant, the three most recent readings for BLFS's Shares Outstanding are $41.4 million (Q3 2021), $40.6 million (Q2 2021), and $33.6 million (Q1 2021).